LETHAL SYSTEMIC GRAFT-VS-HOST DISEASE IN NEONATALLY TOLERANT, BUT NOT IN F(1) HYBRID MICE

被引:3
|
作者
VIZLER, C [1 ]
JANOSSY, T [1 ]
BARANYI, L [1 ]
VEGH, P [1 ]
机构
[1] SZENT GYORGYI ALBERT MED UNIV,INST EXPTL SURG,POB 464,H-6701 SZEGED,HUNGARY
关键词
D O I
10.1006/cimm.1993.1039
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The possibility, conditions, and quantitative aspects of eliciting GVHD in CBA (H-2k) mice made neonatally tolerant to the alloantigens of the donor A (H-2a) strain were studied. The intravenous injection of different doses (107-2 × 108) of A spleen cells caused a severe, often fatal, systemic GVHD in 12-month-old tolerant mice. The GVHD was found to be specific: spleen cells of a third party strain (B10) did not induce any disease. The intensity and the mortality of the GVHD depended on the cell dose and on the age of the recipients. In contrast, unirradiated (CBA × A)F1 recipients proved to be resistant to the lethal disease. In spite of their different susceptibility to the systemic GVHD, the tolerant and F1 hybrid recipients showed equally strong local GVH reactivity in the popliteal lymph node enlargement assay. Neonatally tolerant mice offer a new, sensitive model for the induction of lethal GVHD without the need of immunosuppression or irradiation. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 50 条
  • [41] SERUM FACTORS ASSOCIATED WITH RESISTANCE TO GRAFT-VS-HOST DISEASE IN ADULT F1 RATS
    FITCH, F
    HAMADA, Y
    MCKEARN, T
    STUART, F
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 803 - 803
  • [42] INTRA-ARTERIAL STEROIDS FOR SYSTEMIC STEROID RESISTANT GRAFT-VS-HOST DISEASE
    Stevens, A. M.
    Hu, C.
    Isola, L.
    Scigliano, E.
    Grosskreutz, C.
    Osman, K.
    Malone, A.
    Del Toro, G.
    Weintraub, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 127 - 128
  • [43] Improving Outcomes in Chronic Graft-vs-Host Disease
    Mitchell, Sandra A.
    Cowen, Edward W.
    JAMA DERMATOLOGY, 2024, 160 (04) : 388 - 391
  • [44] Acute graft-vs-host disease: Pathobiology and management
    Goker, H
    Haznedaroglu, IC
    Chao, NJ
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (03) : 259 - 277
  • [45] IMMUNOLOGICAL-UNRESPONSIVENESS BY DEOXYSPERGUALIN THERAPY IN MICE UNDERGOING LETHAL GRAFT-VS-HOST DISEASE, AND SUCCESSFUL ADOPTIVE TRANSFER OF UNRESPONSIVENESS
    NEMOTO, K
    SUGAWARA, Y
    MAE, T
    HAYASHI, M
    ABE, F
    FUJII, A
    TAKEUCHI, T
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 862 - 863
  • [46] A short view of chronic graft-vs-host disease
    Bali, Cagla
    Ozmete, Ozlem
    Ozyilkan, Nesrin Bozdogan
    Akin, Sule
    Aribogan, Anis
    JOURNAL OF CLINICAL ANESTHESIA, 2016, 30 : 4 - 5
  • [47] Graft-vs-host disease as a complication of lung transplantation
    Smith, Douglas M.
    Agura, Edward D.
    Ausloos, Ken
    Ring, W. Steves
    Dorniati-Saad, Rana
    Klintmalm, Goran B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (09): : 1175 - 1177
  • [48] MECHANISM FOR SUPPRESSION OF GRAFT-VS-HOST DISEASE WITH ENDOTOXIN
    THOMSON, PD
    RAMPY, PA
    JUTILA, JW
    JOURNAL OF IMMUNOLOGY, 1978, 120 (04): : 1340 - 1344
  • [49] BLOOD-TRANSFUSIONS AND GRAFT-VS-HOST DISEASE
    RAY, TL
    ARCHIVES OF DERMATOLOGY, 1990, 126 (10) : 1347 - 1350
  • [50] Life-threatening graft-vs-host disease
    Vargas-Díez, E
    García-Díez, A
    Marín, A
    Fernández-Herrara, J
    CLINICS IN DERMATOLOGY, 2005, 23 (03) : 285 - 300